BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28498453)

  • 1. The inhibition of microRNA-15a suppresses hepatitis B virus-associated liver cancer cell growth through the Smad/TGF-β pathway.
    Wang Y
    Oncol Rep; 2017 Jun; 37(6):3520-3526. PubMed ID: 28498453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus regulates apoptosis and tumorigenesis through the microRNA-15a-Smad7-transforming growth factor beta pathway.
    Liu N; Jiao T; Huang Y; Liu W; Li Z; Ye X
    J Virol; 2015 Mar; 89(5):2739-49. PubMed ID: 25540364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma.
    Bi JG; Zheng JF; Li Q; Bao SY; Yu XF; Xu P; Liao CX
    Int J Biochem Cell Biol; 2019 Jan; 106():107-116. PubMed ID: 30503931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-802 induces hepatitis B virus replication and replication through regulating SMARCE1 expression in hepatocellular carcinoma.
    Wang Y; Cao J; Zhang S; Sun L; Nan Y; Yao H; Fan J; Zhu LY; Yu L
    Cell Death Dis; 2019 Oct; 10(10):783. PubMed ID: 31611549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of miR-15a-5p Promotes the Chemoresistance to Pirarubicin in Hepatocellular Carcinoma via Targeting eIF4E.
    Zhang Y; Tie Q; Bao Z; Shao Z; Zhang L
    Comput Math Methods Med; 2021; 2021():6468405. PubMed ID: 34812269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
    J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B Virus-Encoded MicroRNA (HBV-miR-3) Regulates Host Gene PPM1A Related to Hepatocellular Carcinoma.
    Chavalit T; Nimsamer P; Sirivassanametha K; Anuntakarun S; Saengchoowong S; Tangkijvanich P; Payungporn S
    Microrna; 2020; 9(3):232-239. PubMed ID: 31686644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway.
    Wang Y; Wu J; Lin B; Li X; Zhang H; Ding H; Chen X; Lan L; Luo H
    Toxicology; 2014 Dec; 326():9-17. PubMed ID: 25268046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.
    Long J; Jiang C; Liu B; Fang S; Kuang M
    Tumour Biol; 2016 May; 37(5):5821-8. PubMed ID: 26581909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shikonin suppresses progression and epithelial-mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR-106b/SMAD7/TGF-β signaling pathway.
    Li X; Zeng X
    Cell Biol Int; 2020 Feb; 44(2):467-476. PubMed ID: 31617643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus inhibits apoptosis of hepatoma cells by sponging the MicroRNA 15a/16 cluster.
    Liu N; Zhang J; Jiao T; Li Z; Peng J; Cui Z; Ye X
    J Virol; 2013 Dec; 87(24):13370-8. PubMed ID: 24089558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity.
    Wu Q; Liu HO; Liu YD; Liu WS; Pan D; Zhang WJ; Yang L; Fu Q; Xu JJ; Gu JX
    J Biol Chem; 2015 Jan; 290(2):1170-85. PubMed ID: 25422324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Gao F; Sun X; Wang L; Tang S; Yan C
    Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Apoptosis by SYB in HepG2 Liver Cancer Cells is Mediated by the P53/Caspase 9 Axis.
    Sharula ; Wu Z
    Anticancer Agents Med Chem; 2017; 17(7):941-947. PubMed ID: 28356025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
    Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
    Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-allylmercaptocysteine promotes MAPK inhibitor-induced apoptosis by activating the TGF-β signaling pathway in cancer cells.
    Tong D; Qu H; Meng X; Jiang Y; Liu D; Ye S; Chen H; Jin Y; Fu S; Geng J
    Oncol Rep; 2014 Sep; 32(3):1124-32. PubMed ID: 24970681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of miR-340 on hepatocellular carcinoma by targeting the DcR3 gene.
    Xie L; Chen Z; Liu H; Guan L; Wang Z; Li W
    Dig Liver Dis; 2018 Mar; 50(3):291-296. PubMed ID: 29311025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.